Analyst consensus rating
CNS Pharmaceuticals Analyst Rating: none
CNSP is rated none by 1 analysts with a $10.00 target. As of 2026-08-29.
Direct answer
CNS Pharmaceuticals's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.00.
Forecast evidence checked August 29, 2026.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $5.52
- Average price target
- $10.00
- High price target
- $10.00
- Low price target
- $10.00
- Low target gap
- +81.1%
- Target upside
- +81.1%
- High target gap
- +81.1%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CNS Pharmaceuticals?
CNS Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $10.00.
How far are CNS Pharmaceuticals's low and high targets from the recorded price?
The low target implies +81.1%, while the high target implies +81.1%.
How many analysts are included in CNS Pharmaceuticals's consensus?
The verified consensus includes 1 analysts.
How is CNS Pharmaceuticals's target upside or downside calculated?
The average target of $10.00 is divided by the recorded price of $5.52, then one is subtracted to produce +81.1%. This does not guarantee a future return.
When was CNS Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.